Autoimmune responses to the β cell autoantigen, insulin, and the INS VNTR-IDDM2 locus

Clinical and Experimental Immunology

Volumn 114, Issue 3, 1998, Pages 370-376

  Sarugeri, E ^a   Dozio, N ^a   Belloni, C ^a   Meschi, F ^a   Pastore, M R ^a   Bonifacio, E ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Autoantibody; Cell mediated immunity; Genetics; Insulin; Type 1 diabetes

Indexed keywords

AUTOANTIGEN; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; ALLELES; ANTIBODY FORMATION; AUTOANTIGENS; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HLA-DR3 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS; IMMUNITY, CELLULAR; INFANT; INSULIN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS;

EID: 0031766035     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00744.x     Document Type: Article

References (40)

1. Bonifacio E, Bingley PJ. Islet autoantibodies and their use in predicting insulin-dependent diabetes. Acta Diabetol 1997; 34:185-93.
2. Roep B. T-cell responses to autoantigens in IDDM. Diabetes 1996; 45:1147-56.
3. Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG. Evidence for a long pre diabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet 1981; 2:1363-5.
4. Roll U, Ziegler AG. Combined antibody screening for improved prediction of IDDM - modern strategies. Exp Clin Endocrinol Diabetes 1997; 105:1-14.
5. Vardi P, Ziegler AG, Mathews JH et al. Concentration of insulin autoantibodies at onset of type 1 diabetes - inverse log-linear correlation with age. Diabetes Care 1988; 11:736-9.
6. MacCuish AC, Jordan J, Campbell CJ, Duncan LPJ, Irvine WJ. Cell-mediated immunity in diabetes mellitus. Lymphocyte transformation by insulin and insulin fragments in insulin-treated and newly-diagnosed diabetics. Diabetes 1975; 24:36-43.
7. Keller RJ. Cellular immunity to human insulin in individuals at high risk for the development of type 1 diabetes mellitus. J Autoimmun 1990; 3:321-7.
8. Harrison LC, DeAizpurua H, Loudovaris T, Campbell IL, Cebon JS, Tait BD, Colman PG. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes 1991; 40:1128-33.
9. Harrison LC, Chu SX, DeAizpurua HJ, Graham M, Honeyman MC, Colman PG. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J Clin Invest 1992; 89:1161-5.
10. Atkinson MA, Bowman MA, Kao KJ, Campbell L, Dush PJ, Shah SC, Simell O, Maclaren NK. Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med 1993; 329:1853-8.
11. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994; 94:2125-9.
12. Durinovic-Bellò I, Hummel M, Ziegler AG. Cellular immune response to diverse islet cell antigens in IDDM. Diabetes 1996; 45:795-800.
13. Schloot NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, Eisenbarth GS. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 1997; 40:564-72.
14. Daniel D, Gill RG, Schloot N, Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995; 25:1056-62.
15. Atkinson MA, Maclaren NK, Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 1990; 39:933-7.
16. Thivolet CH, Goillot E, Bedossa P, Durand A, Bonnard M, Orgiazzi J. Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetologia 1991; 34:314-9.
17. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 1991; 88:10252-6.
18. Harrison LC, Dempsey-Collier M, Kramer DR, Takahashi K. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J Exp Med 1996; 184:2167-74.
19. Kobayashi T, Nakanishi K, Murase T, Kosaka K. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 1996; 45:622-6.
20. Harrison LC. Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes. Mol Med 1995; 1:722-7.
21. Roll U, Christie MR, Füchtenbusch M, Payton MA, Hawkes CJ, Ziegler AG. Perinatal autoimmunity in offspring of diabetic parents. The German multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 1996; 45:967-73.
22. Ziegler AG, Standl E, Albert E, Mehnert H. HLA-associated insulin autoantibody formation in newly diagnosed type 1 diabetic patients. Diabetes 1991; 40:1146-9.
23. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984; 33:176-83.
24. Bennett ST, Lucassen AM, Gough SCL et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 1995; 9:284-92.
25. Pugliese A, Zeller M, Fernandez A et al. The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genet 1997; 15:293-7.
26. Vafiadis P, Bennett ST, Todd JA et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Genet 1997; 15:289-92.
27. Williams AJK, Bingley PJ, Bonifacio E, Palmer JP, Gale EAM. A novel micro-assay for insulin-autoantibodies. J Autoimmun 1997; 10:473-8.
28. Naserke HE, Dozio N, Ziegler AG, Bonifacio E. Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia, 1998; 41:681-3.
29. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, Bottazzo GF. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335:147-9.
30. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantations. Tissue Antigens 1992; 39:225-35.
31. Bein G, Glaser R, Kirchner H. Rapid HLA-DRB1 genotyping by nested PCR amplification. Tissue Antigens 1992; 39:68-73.
32. Zhang J, Weiner HL, Hafler DA. Autoreactive T-cells in multiple sclerosis. Int Rev Immunol 1992; 9: 183-201.
33. Kotanko P. Type 1 diabetes and the 'milk hypothesis'. Diabetes Care 1997; 20:233-4.
34. Harrison LC, Honeyman MC, DeAizpurua HJ, Schmidli RS, Colman PG, Tait BD, Cram DS. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993; 341:1365-9.
35. Roep BO, Duinkerken G, Schreuder GMT, Kolb H, de Vries RRP, Martin S. HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol 1996; 26:1285-9.
36. Ellis TM, Darrow B, Campbell L, Atkinson MA. Inverse relationship between humoral and cellular immune responses to glutamate decarboxylase 65 (GAD) and insulin in IDDM. Diabetes 1995; 44s:52A.
37. Hummel M, Durinovic-Bellò I, Ziegler AG. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. J Autoimmun 1996; 9:427-30.
38. Manca F, Fenoglio D, Li Pira G, Kunkl A, Celada F. Effect of antigen/ antibody ratio on macrophage uptake, processing and presentation to T cells of antigen complexed with polyclonal antibodies. J Exp Med 1991; 173:37-48.
39. Watts C, Lanzavecchia A. Suppressive effect of antibody on processing of T cell epitopes. J Exp Med 1993; 178:1459-63.
40. Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II Major Histocompatibility Complex presentation of different T cell determinants. J Exp Med 1995; 181:1957-63.